Hepatitis is inflammation or swelling of the liver. It is usually caused by a viral infection. It can also be due to other causes, such as an autoimmune condition, medicines, or alcohol use.
Hepatitis can be acute (sudden) or chronic (long-lasting). Treatment for hepatitis depends on the specific type or cause.
The liver is a large organ in the upper right side of the belly. The liver helps remove toxins and waste from the blood. It helps in the digestion of fats and proteins. The liver makes bile, a fluid that helps break down fats. It also stores glycogen, a form of glucose (sugar) the body uses for energy.
Signs and symptoms of hepatitis include:
People infected with hepatitis B or C as children may develop chronic hepatitis. Most people with chronic hepatitis do not have symptoms at first. But chronic infection can damage the liver and cause scarring (cirrhosis) of the liver and other problems. In rare cases, damage can lead to liver failure.
Signs of liver damage include:
There are different types of hepatitis based on the underlying cause.
Viruses are the most common cause of hepatitis. These include:
Sometimes toxic substances can cause hepatitis. These include chemicals, poisons, and medicines. High doses of over-the-counter medicines and supplements can put stress on the liver and cause damage.
In rare cases, chronic hepatitis can develop if the immune system attacks the liver.
Heavy alcohol use can cause hepatitis over time.
Viral forms of hepatitis can be spread through contact with blood or other body fluids. Some types are spread through contaminated food or water or by not washing hands. Certain factors put a person at higher risk for viral hepatitis.
If a person received blood products that were not screened for infections, they are at higher risk for hepatitis. Blood products are now routinely tested for Hepatitis B and C in most countries around the world. Blood products include whole blood, platelets, fresh frozen plasma, packed red blood cells, granulocytes (white blood cells), cryoprecipitate, immunoglobulin preparations (IVIG, VZIG), and bone marrow or stem cells from another person (allogeneic transplant).
In the United States, routine screening of blood donors for the hepatitis B virus began in 1971. For hepatitis C, accurate screening began in 1992.
Risk factors vary by type of hepatitis, but general risk factors include:
Your health care provider will do a physical exam and health history. They may ask about risk factors and exposure including travel, blood products, alcohol and drug use, and potential contact with other people with hepatitis.
Lab tests may include tests to check for viral infection, inflammation, and liver function.
Imaging tests or scans of the liver may include ultrasound (sonogram), CT scan, or MRI.
A liver biopsy may be done to confirm diagnosis and check for liver damage.
Acute hepatitis often goes away on its own. Care for hepatitis includes rest, drinking plenty of fluids, and eating a healthy diet.
Some types of hepatitis can be treated with antiviral medicines.
Autoimmune hepatitis may be treated with medicines that suppress the immune system.
People at high risk should be screened for hepatitis. Early diagnosis and treatment of hepatitis can help prevent more serious complications. Chronic hepatitis can cause liver problems including cirrhosis, liver cancer, and liver failure. In some cases, patients may need a liver transplant.
There are steps you can take to prevent the spread of germs, including the virus that causes hepatitis. Ways to reduce your risk of hepatitis include:
To maintain good liver health, patients should:
—
The Together by St. Jude™ online resource does not endorse any branded product mentioned in this article.
—
Reviewed: October 2024
Children with serious illnesses can be more vulnerable to infections. Learn more about ways you can protect your child.
A cancer survivorship care plan is a record of your cancer treatments and follow-up care plan. Learn more about cancer survivorship care plan.
Some childhood cancer treatments may damage the liver. Learn about liver late effects in pediatric cancer survivors.